ELEVIDYS Trademark
Trademark Overview
On Monday, May 8, 2023, a trademark application was filed for ELEVIDYS with the United States Patent and Trademark Office. The USPTO has given the ELEVIDYS trademark a serial number of 97925396. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, November 19, 2024. This trademark is owned by Sarepta Therapeutics, Inc.. The ELEVIDYS trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular d...
General Information
| Serial Number | 97925396 |
| Word Mark | ELEVIDYS |
| Filing Date | Monday, May 8, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Tuesday, November 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, November 19, 2024 |
Trademark Statements
| Description of Mark | The mark consists of an oval shape comprised of three alternately-shaded curved bands increasing in size to an vesica piscis center and three alternately-shaded curved bands decreasing in size on the other side of the center and followed by "ELEVIDYS". |
| Goods and Services | Pharmaceutical preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations based on morpholino oligomer technology platform for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Pharmaceutical preparations that modulate RNA expression for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders, and for the regulation of protein production; Gene therapy products, namely, gene delivery pharmaceuticals; Pharmaceutical preparations for gene therapy, gene editing, and genome editing; Gene therapy products in the nature of pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Biological preparations for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Viruses, viral vectors and viral constructs being pharmaceuticals for the treatment of neuromuscular diseases and disorders, muscular dystrophies, central nervous system diseases and disorders, genetic diseases and disorders; Pharmaceutical preparations, biological preparations and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of genetic disorders and diseases |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, June 6, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | Sarepta Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
Trademark Events
| Event Date | Event Description |
| Thursday, May 11, 2023 | NEW APPLICATION ENTERED |
| Tuesday, June 6, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, June 7, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Wednesday, January 31, 2024 | ASSIGNED TO EXAMINER |
| Wednesday, January 31, 2024 | NON-FINAL ACTION WRITTEN |
| Wednesday, January 31, 2024 | NON-FINAL ACTION E-MAILED |
| Wednesday, January 31, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, April 23, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Tuesday, April 23, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Thursday, July 25, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, July 25, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 25, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, August 2, 2024 | FINAL REFUSAL E-MAILED |
| Friday, August 2, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, August 2, 2024 | FINAL REFUSAL WRITTEN |
| Wednesday, October 2, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 2, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, October 2, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, October 9, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, November 13, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, November 19, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, November 19, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
